ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Quinoline compounds >1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride

1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride

1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Suppliers list
Company Name: Hangzhou Sage Chemical Co., Ltd.  
Tel: +86057186818502 13588463833
Email: info@sagechem.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: +86-21-60341587
Email: sales@topbiochem.com
Company Name: Shanghai Raise Chemical Technology Co.,Ltd  
Tel: +86-021-50935922
Email:
Company Name: ShangHai AmK Pharmaceutical Technology Co., Ltd.  
Tel: 微信 18019252918 18019252918
Email: sale@amkchem.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.  
Tel: 025-66028182 17714375163
Email: yftan@aikonchem.com

1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride manufacturers

1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Basic information
Application
Product Name:1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride
Synonyms:4-Methyl-2,3-dihydro-1H-quinoxaline;1-Methyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride, 95+%;4-methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine dihydrochloride;Quinoxaline, 1,2,3,4-tetrahydro-1-methyl-;1-METHYL-1,2,3,4-TETRAHYDRO-QUINOXALINE DIHYDROCHLORIDE ISO 9001:2015 REACH;1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride
CAS:36438-97-8
MF:C9H12N2
MW:148.21
EINECS:
Product Categories:
Mol File:36438-97-8.mol
1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Structure
1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Chemical Properties
Melting point 40.5-42℃
Boiling point 163-169 °C(Press: 21 Torr)
density 1.033±0.06 g/cm3(Predicted)
pka7.41±0.20(Predicted)
CAS DataBase Reference36438-97-8
Safety Information
MSDS Information
1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Usage And Synthesis
ApplicationMethyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride exhibits glutamate receptor antagonism, high affinity for AMPA receptors (non-NMDA receptors), and strong inhibitory effects on the neurotoxicity of phycocyanin, thus inhibiting auditory convulsions. It also possesses high solubility and can serve as an inhibitor of phycocyanin neurotoxicity in its active ingredient. Furthermore, 1-methyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride compounds are important intermediates in organic synthesis, used to prepare various fine chemical products, such as dyes (WO1999051688A1) or poly(phenylquinoxaline) derivatives, the latter being a crucial structural unit in organic polymer light-emitting diodes (LEDs).
SynthesisTake a 100 ml single-necked bottle, add 1-methyl-quinoxaline-6-carboxylic acid methyl ester (3) 3.76 g (0.02 mol), and add methanol 50 ml, stirring to dissolve, and then add slowly into the sodium borohydride 3.02 g (0.08 mol). 90 C. Reaction was carried out for 2 hours, and after completion of the reaction, excess methanol was evaporated under reduced pressure, and then after extraction and drying to obtain 1-methyl-1,2, 3,4-tetrahydroquinoxaline-6-carboxylic acid methyl ester 3.34 g. 87% yield. 3,4-tetrahydroquinoxaline-6-carboxylic acid methyl ester 3.34 g, yield 87%. Take a 100 ml single-necked bottle, add 1-methyl-1,2,3,4-tetrahydroquinoxaline-6-carboxylic acid methyl ester, and add methanol 50 ml, stirring to dissolve, and then add slowly into the hydrochloric acid fully hydrolyzed to obtain 1-methyl-1,2,3,4-tetrahydroquinoxaline dihydrochloride.
1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride Preparation Products And Raw materials
Tag:1-Methyl-1,2,3,4-tetrahydro-quinoxaline dihydrochloride(36438-97-8) Related Product Information
1,2,3,4-Tetrahydro-quinoxaline 1-(2,6-Dichlorobenzyl)-3-methyl-4-(4-methylbenzoyl)-3,4-dihydro-2(1H)-quinoxalinone 1-(3,4-Dichlorobenzyl)-3-methyl-4-[3-(trifluoromethyl)benzoyl]-3,4-dihydro-2(1H)-quinoxalinone 4-(4-Chlorobenzoyl)-1-(3,4-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-(4-Chlorobenzoyl)-1-(2,6-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-(4-Chlorobenzoyl)-1-(4-chlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-Benzoyl-1-(3,4-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-(4-Chlorobenzoyl)-1-(2-chloro-6-fluorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(2,6-Dichlorobenzyl)-4-(4-fluorobenzoyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(2,6-Dichlorobenzyl)-4-(2,4-difluorobenzoyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-Benzoyl-1-(2,4-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(2,6-Dichlorobenzyl)-4-(2,6-difluorobenzoyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 4-(4-Chlorobenzoyl)-1-(2,4-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(2,6-Dichlorobenzyl)-3-methyl-4-[3-(trifluoromethyl)benzoyl]-3,4-dihydro-2(1H)-quinoxalinone 4-Benzoyl-1-(2,6-dichlorobenzyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(3,4-Dichlorobenzyl)-4-(4-fluorobenzoyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 1-(2,4-Dichlorobenzyl)-4-(4-fluorobenzoyl)-3-methyl-3,4-dihydro-2(1H)-quinoxalinone 5-[(2,5-Dichlorophenyl)sulfonyl]-7-(trifluoromethyl)-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoxaline